A detailed history of First Manhattan CO transactions in Pfizer Inc stock. As of the latest transaction made, First Manhattan CO holds 466,693 shares of PFE stock, worth $12.5 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
466,693
Previous 559,401 16.57%
Holding current value
$12.5 Million
Previous $15.7 Million 13.71%
% of portfolio
0.04%
Previous 0.05%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$27.7 - $31.39 $2.57 Million - $2.91 Million
-92,708 Reduced 16.57%
466,693 $13.5 Million
Q2 2024

Aug 13, 2024

SELL
$25.26 - $29.6 $644,028 - $754,681
-25,496 Reduced 4.36%
559,401 $15.7 Million
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $1.43 Million - $1.64 Million
-55,100 Reduced 8.61%
584,897 $16.2 Million
Q4 2023

Feb 13, 2024

SELL
$26.13 - $33.94 $2.64 Million - $3.42 Million
-100,880 Reduced 13.62%
639,997 $18.4 Million
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $9.34 Million - $10.9 Million
-291,178 Reduced 28.21%
740,877 $24.6 Million
Q2 2023

Aug 14, 2023

SELL
$36.12 - $41.79 $1.59 Million - $1.83 Million
-43,883 Reduced 4.08%
1,032,055 $37.9 Million
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $1.48 Million - $1.92 Million
-37,500 Reduced 3.37%
1,075,938 $43.9 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $465,596 - $607,784
-11,152 Reduced 0.99%
1,113,438 $57.1 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $375,592 - $458,503
8,583 Added 0.77%
1,124,590 $49.2 Million
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $445,710 - $528,473
-9,579 Reduced 0.85%
1,116,007 $58.5 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $1.69 Million - $2.09 Million
36,952 Added 3.39%
1,125,586 $58.3 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $623,932 - $924,875
-15,100 Reduced 1.37%
1,088,634 $64.3 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $446,782 - $573,930
-11,383 Reduced 1.02%
1,103,734 $47.5 Million
Q2 2021

Aug 16, 2021

SELL
$35.91 - $40.68 $277,979 - $314,903
-7,741 Reduced 0.69%
1,115,117 $43.7 Million
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $357,170 - $402,817
-10,665 Reduced 0.94%
1,122,858 $40.7 Million
Q4 2020

Feb 16, 2021

SELL
$33.47 - $42.56 $878,085 - $1.12 Million
-26,235 Reduced 2.26%
1,133,523 $41.7 Million
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $11.6 Million - $13.7 Million
-366,836 Reduced 24.03%
1,159,758 $42.6 Million
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $14 Million - $17 Million
-465,100 Reduced 23.35%
1,526,594 $49.9 Million
Q1 2020

May 06, 2020

SELL
$27.03 - $38.62 $28.3 Million - $40.4 Million
-1,046,596 Reduced 34.45%
1,991,694 $65 Million
Q4 2019

Feb 13, 2020

SELL
$32.92 - $37.36 $7.43 Million - $8.43 Million
-225,579 Reduced 6.91%
3,038,290 $119 Million
Q3 2019

Nov 13, 2019

SELL
$32.49 - $42.13 $26.5 Million - $34.3 Million
-814,571 Reduced 19.97%
3,263,869 $117 Million
Q2 2019

Aug 16, 2019

SELL
$36.98 - $41.52 $12.7 Million - $14.2 Million
-342,279 Reduced 7.74%
4,078,440 $177 Million
Q1 2019

Apr 12, 2019

SELL
$37.5 - $41.2 $8.59 Million - $9.44 Million
-229,006 Reduced 4.93%
4,420,719 $188 Million
Q4 2018

Jan 30, 2019

SELL
$38.47 - $43.86 $9.9 Million - $11.3 Million
-257,288 Reduced 5.24%
4,649,725 $203 Million
Q3 2018

Oct 15, 2018

SELL
$34.47 - $41.81 $5.99 Million - $7.27 Million
-173,900 Reduced 3.42%
4,907,013 $216 Million
Q2 2018

Aug 01, 2018

BUY
$32.98 - $35.16 $1.7 Million - $1.82 Million
51,658 Added 1.03%
5,080,913 $184 Million
Q1 2018

Apr 20, 2018

SELL
$31.91 - $37.02 $1.24 Million - $1.44 Million
-38,962 Reduced 0.77%
5,029,255 $178 Million
Q4 2017

Jan 22, 2018

BUY
$33.26 - $35.29 $216,722 - $229,949
6,516 Added 0.13%
5,068,217 $184 Million
Q3 2017

Oct 25, 2017

BUY
$31.0 - $34.15 $157 Million - $173 Million
5,061,701
5,061,701 $181 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track First Manhattan CO Portfolio

Follow First Manhattan CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.